Pharmacokinetics of concomitantly administered foscarnet and zidovudine for treatment of human immunodeficiency virus infection (AIDS Clinical Trials Group protocol 053)
- 1 August 1992
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 36 (8) , 1773-1778
- https://doi.org/10.1128/aac.36.8.1773
Abstract
Foscarnet and zidovudine (ZDV) pharmacokinetic parameters were not altered in five patients receiving 14 days of concomitant therapy. Foscarnet clearance in plasma averaged (+/- standard deviation) 0.16 +/- 0.03 and 0.13 +/- 0.05 liter/h/kg of body weight in the absence and presence of ZDV. ZDV parameters were also not significantly altered, with a mean (+/- standard deviation) oral clearance of 2.7 +/- 1.0 and 2.6 +/- 0.8 liter/h/kg for the 2 study days, respectively.Keywords
This publication has 17 references indexed in Scilit:
- In Vivo Additive Antiretroviral Effect of Combined Zidovudine and Foscarnet Therapy for Human Immunodeficiency Virus Infection (ACTG Protocol 053)The Journal of Infectious Diseases, 1991
- Pharmacokinetics of oral zidovudine (azidothymidine) in patients with AIDS when administered with and without a high-fat mealAIDS, 1990
- Clinical Pharmacokinetics of ZidovudineClinical Pharmacokinetics, 1989
- Pharmacokinetics of foscarnet and distribution to cerebrospinal fluid after intravenous infusion in patients with human immunodeficiency virus infectionAntimicrobial Agents and Chemotherapy, 1989
- Pharmacokinetics of intermittently administered intravenous foscarnet in the treatment of acquired immunodeficiency syndrome patients with serious cytomegalovirus retinitisAntimicrobial Agents and Chemotherapy, 1989
- Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndromeAntimicrobial Agents and Chemotherapy, 1989
- Combinations of 3'-azido-3'-deoxythymidine (zidovudine) and phosphonoformate (foscarnet) against human immunodeficiency virus type 1 and cytomegalovirus replication in vitroAntimicrobial Agents and Chemotherapy, 1989
- Inhibition of human immunodeficiency virus in vitro by combinations of 3'-azido-3'-deoxythymidine and foscarnetAntimicrobial Agents and Chemotherapy, 1989
- Simultaneous quantification of zidovudine and its glucuronide in serum by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1988
- INHIBITION OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE III IN VITRO BY PHOSPHONOFORMATEThe Lancet, 1985